// App-Quantinova.ai

: Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study

Researchers

Presenter

  • Chantal Raherison-Semjen

Principal Investigators

  • Dave Singh

  • Huib A.M Kerstjens

  • Christian Gessner

  • Ana-Maria Tanase

  • David Lawrence

  • Abhijit Pethe

  • Karen Mezzi

  • Peter D'Andrea

Medical Centers

  • Novartis Pharmaceuticals Corporation East Hanover NJ United States

  • Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom,

  • Universitätsklinikum Leipzig, Leipzig, Germany; POIS Leipzig GbR, Leipzig, Germany

  • BPH Bordeaux Population Health Research Center, Université de Bordeaux, ISPED Institut de Santé Publique d'Épidémiologie et de Développement, Bordeaux, France

  • Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands

  • Novartis AG, Basel, Switzerland

Locations

  • United States

  • United Kingdom

  • Switzerland

  • Germany

  • France

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Seebri Breezhaler

  • indacaterol

  • Mometasone furoate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • NCT02571777

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved